Is Legend Biotech (LEGN) One of the Overlooked Growth Stocks to Buy Now? [Yahoo! Finance]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Yahoo! Finance
Legend Biotech Corporation (NASDAQ: LEGN ) is one of the overlooked growth stocks to buy now. Earlier on March 10, Legend Biotech reported financial results for the full year 2025, headlined by the continued commercial success of its multiple myeloma therapy, CARVYKTI. The treatment generated net trade sales of ~$555 million in Q4 and $1.9 billion for 2025, leading the CARVYKTI franchise to achieve full-year profitability. This growth was supported by a significant increase in collaboration revenue, which rose to $277.6 million in the final quarter. The company reached a major clinical milestone in 2025, surpassing 10,000 patients treated with CARVYKT across clinical and commercial settings. To support this rising demand, Legend Biotech expanded its Raritan manufacturing facility, making it the largest cell therapy production site in the US with the capacity to treat 10,000 patients annually. Is Legend Biotech (LEGN) One of the Overlooked Growth Stocks to Buy Now? Mila Supinska
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Legend Biotech: Undervalued Leader In The CAR-T Race [Seeking Alpha]Seeking Alpha
- Legend Biotech CARVYKTI Milestones Contrast With Mixed Long Term Share Returns [Yahoo! Finance]Yahoo! Finance
- Legend Biotech (LEGN) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.MarketBeat
- Why Legend Biotech Stock Crushed the Market on Monday [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Why Legend Biotech Stock Crushed the Market on Monday [Yahoo! Finance]Yahoo! Finance
LEGN
Sec Filings
- 4/14/26 - Form 6-K
- 3/27/26 - Form 4
- 3/26/26 - Form 144
- LEGN's page on the SEC website